Author Archive: Daniel Seaton

Daniel Seaton

Daniel Seaton is Manager of Event & Health Communications, working on communications for BIO’s events and health care policy issues. Prior to joining BIO in August 2013, he spent four years in communications at the Pharmaceutical Research and Manufacturers of America. The best part of his job is educating audiences about the many benefits the bioscience industry produces for patients, consumers, and the economy as a whole. Daniel enjoys hiking, camping, and, when he can find a game, playing bridge. Having grown up in New Mexico, one of his favorite foods is roasted green chile. He is currently finishing up a Master’s degree in communications at Georgetown University.

Latest Posts

New Report: Innovation in Hepatitis C Treatment

chi-logo-small

Today, the California Healthcare Institute released a report on the public health impact of Hepatitis C and the potential of groundbreaking new treatments to save tens of thousands of lives over the coming decades. Innovation in Hepatitis C Treatment: New Opportunities for Action explores the incredible progress that has been made in Hepatitis C treatment in the decades since the Hepatitis C virus was identified as the cause of the disease in 1989. Early treatments Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

The Value of Prevention

Copyright sanofi pasteur

Vaccines are widely recognized as one of the most important advances in medical history. Once-devastating diseases like polio, which at its peak claimed the lives of nearly 6,000 Americans each year, have been nearly eradicated. A report issued by the CDC in April estimated that vaccines will prevent 732,000 deaths and 21 million hospitalizations among children born in the US over the past 20 years. Despite this track record of overwhelming success, a recent New Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

New CDC Tool to Track Antibiotic Use & Resistance

MRSA

Antibiotic resistance is quickly becoming one of the most serious threats facing our health care system. Last fall, the CDC issued a report which found that 2 million people acquire an antibiotic resistant infection each year in the US, of whom at least 23,000 die as a result. To help address this threat, the CDC is releasing a new tool, the Antibiotic Use and Resistance (AUR) reporting module, which will enable all hospitals in the Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Innovation Zone Company Snapshot: HemoShear LLC

InnovationZone_Logo_SBIR Companies_VERT_lockup

Next week in San Diego at the BIO International Convention, BIO will be partnering with the National Institutes of Health (NIH) and the National Science foundation (NSF) to host the first-ever BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Companies are rigorously vetted through the NIH and NSF SBIR review process prior to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Innovation Zone Company Snapshots: Privo Technologies

InnovationZone_Logo_SBIR Companies_VERT_lockup

Later this month at the BIO International Convention, BIO will be partnering with the National Science Foundation (NSF) and the National Institutes of Health (NIH) to host the first-ever BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Companies are rigorously vetted through the NIH and NSF SBIR review process prior to receiving the Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,